semaglutide 503a US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs Compounded Semaglutide: Safety & Regulation

For instance, postmenopausal women and older adults might experience different metabolic effects and may have varying degrees of sensitivity to Semaglutides actions

Jhawar N, Wang JV, Saedi N

The Workforce Impact of GLP-1s Obesity is a major risk factor for several health issues, such as high blood pressure, type 2 diabetes, heart disease, osteoarthritis, and sleep apnea, which can present significant challenges in the workforce, such as higher healthcare claims, reduced productivity, increased sick leave, and a greater risk of both short- and long-term disabilities

Allergic responses to semaglutide or excipients in the formulation can manifest with pruritus, urticaria (hives), or more serious symptoms

The semaglutide to tirzepatide dose conversion chart provides guidance for translating between these medications